FTC Settles with NextMed Over Deceptive Pricing, Hidden Material Terms, and Fake Reviews and Testimonials in Telehealth Membership Programs

This week, the Federal Trade Commission (FTC) announced a settlement with NextMed parent company Southern Health Solutions, Inc., in response to allegations that the telemedicine platform offered deceptive claims and fake reviews to lure consumers into buying its programs. The FTC charged that NextMed and its founders sold fixed-term weight-loss memberships that provided access to GLP-1 drugs…